… use of sestamibi tomography imaging in humans with pathological infarct size as a reference
standard. On the basis of our results, we can state that 99m Tc sestamibi tomography is an …

… sestamibi SPECT in a large population of heart transplant recipients. Our findings indicate
that quantitative technetium-99m sestamibi … imaging approach in heart transplant recipients. …

… -sestamibi as a viability marker. In a recently reported study 19 using explanted hearts from
transplant … scar quantified by 99m Tc-sestamibi SPECT and the actual pathological scar size. …

… ACR and CAV remains a priority objective for heart transplant professionals. In this review we
will… (echocardiography, cardiac computed tomography, myocardial perfusion imaging, and …

… by dobutamine echocardiography and sestamibi single-photon emission computed
tomography/fluorodeoxyglucose positron emission tomography underwent BMC transplantation (1 × …

… Thirty-eight patients with prior heart transplantation who underwent CZT SPECT and 13 N-NH
3 PET dynamic scans were included in this study. CZT SPECT with 99m Tc-sestamibi was …

… We evaluate the feasibility and safety of coronary computed tomography angiography (CCTA)
as the first-line investigation in heart transplant patients and the rate of coronary allograft …

… as technetium Tc 99m sestamibi single photon emission computed tomography (SPECT),
is … Sestamibi distributes in the myocardium in proportion to flow, 16 and cardiac uptake is …

… Between April 2003 and July 2004, 53 consecutive heart transplant patients underwent
16-slice CT within the 24 h before or after their annual routine CCA. Exclusion criteria were …

… sestamibi is sequestered largely within viable mitochondria by the large negative transmembrane
potential.lx Nonviable myocytes do not sequester 99mT~labeled sestamibi… tomography …